S104 Cost-effectiveness of triple therapy with budesonide/glycopyrronium/formoterol fumarate versus dual therapies in moderate-to-very severe COPD in the United Kingdom: analysis based on the KRONOS study
E. de Nigris, U. Holmgren, C. Treharne, N. Brighton, A. Walker, J. Haughney
{"title":"S104 Cost-effectiveness of triple therapy with budesonide/glycopyrronium/formoterol fumarate versus dual therapies in moderate-to-very severe COPD in the United Kingdom: analysis based on the KRONOS study","authors":"E. de Nigris, U. Holmgren, C. Treharne, N. Brighton, A. Walker, J. Haughney","doi":"10.1136/thorax-2021-btsabstracts.110","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":215643,"journal":{"name":"Ease that wheeze: managing risk in COPD","volume":"63 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ease that wheeze: managing risk in COPD","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/thorax-2021-btsabstracts.110","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}